AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Israeli defense firms target Asia as Singapore Airshow opens amid regional arms race
2
Israeli startup raises $6.2 million to turn social media video into intelligence
3
Chinese fund: “The Chinese government has imposed a ban on any new investment in Israel”
4
Cyera employees to sell tens of millions in shares at $9 billion valuation
5
Medtronic to acquire Israeli AI cardiology firm CathWorks for $585 million, deal could reach $1 billion
More news

Lawsuit

4 stories about Lawsuit
חברת ה תרופות טבע Teva

Fresh Teva Lawsuit Goes Against Dividends Paid by Debt Heavy Drugmaker

30.11.17|Anat Rouah
Tel Aviv-based capital investment firm Tulip Capital is threatening derivative action against Teva, saying the company's huge debt load renders its dividends unlawful
בנימין נתניהו עם מנכ"ל אינטל בריאן קרזניץ' וראשי מובילאיי פרופ' אמנון שעשוע והמנכ"ל זיו אבירם

SEC Expands Probe into Mobileye Insider Trading Charges

19.11.17|Tomer Ganon and Ran Abramson
On Wednesday, the U.S. Securities and Exchange Commission filed a request for Israeli assistance in the two Mobileye insider trade cases
מימין מנכ"ל מובילאיי זיו אבירם והיו"ר אמנון שעשוע

Defendant Denies Mobileye Insider Trading Charges

15.10.17|Tomer Ganon and Ran Abramson
Richmond, Virginia resident Roger E. Shaoul said he “acted in good faith” in documents filed to court. In March, Intel announced it signed an agreement to buy Mobileye for $15.3 billion
מוסף שבועי 14.9.17 פרופ' גידי גרוס

Kite Pharma Sale Triggers Scientist Quarrel

02.10.17|Zohar Shahar Levy
Zelig Eshhar who patented the company’s core technology is now being sued by his former PhD student and current pharma entrepreneur
Previous Articles